Meeting
2023 ASCO Annual Meeting
Deep learning to estimate RECIST in cancer patients treated in real-world settings.
Authors
Irbaz Bin Riaz
Dana-Farber Cancer Institute, Boston, MA
Irbaz Bin Riaz , Noman Ashraf , Gordon J Harris , Toni K. Choueiri , Kenneth L. Kehl
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Clinical Informatics/Advanced Algorithms/Machine Learning
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1564)
DOI
10.1200/JCO.2023.41.16_suppl.1564
Abstract #
1564
Poster Bd #
158
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
ml-RECIST: Machine learning to estimate RECIST in patients with NSCLC treated with PD-(L)1 blockade.
First Author: Kathryn Cecilia Arbour
Poster
2023 ASCO Annual Meeting
Enhancement in line of therapy (LoT) derivation from real-world data (RWD) from electronic health records (EHR) via integration of medical claims data.
First Author: Smita Agrawal
Poster
2023 ASCO Annual Meeting
Prediction of cancer treatment response from histopathology images through imputed transcriptomics.
First Author: Danh-Tai Hoang
Poster
2022 ASCO Annual Meeting
Efficacy of afatinib in patients with advanced/metastatic solid tumors harboring NRG1 gene fusions: A novel, prospective real-world outcomes study based on single-patient protocol data.
First Author: Stephen V. Liu